These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8267501)

  • 21. Ventricular tachycardia and sudden cardiac death.
    Reddy PC; Tandon N; Stafford PR
    J La State Med Soc; 1999 May; 151(5):281-7. PubMed ID: 10363484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of non-invasive and invasive studies in patients with bundle branch block, syncope and history of myocardial infarction.
    Brembilla-Perrot B; Suty-Selton C; Houriez P; Claudon O; Beurrier D; de la Chaise AT
    Europace; 2001 Jul; 3(3):187-94. PubMed ID: 11467459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery for ventricular tachycardia in patients undergoing left ventricular reconstruction by the Dor procedure.
    Sartipy U; Albåge A; Strååt E; Insulander P; Lindblom D
    Ann Thorac Surg; 2006 Jan; 81(1):65-71. PubMed ID: 16368337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases].
    Fleurant E; Lacroix D; Klug D; Warembourg H; Kacet S; Lekieffre J
    Arch Mal Coeur Vaiss; 1996 Apr; 89(4):435-44. PubMed ID: 8763003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
    Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of searching ventricular late potentials in patients recovering from ventricular fibrillation].
    Leclercq JF; Gounaropoulou N; Cauchemez B; Chouty F; Leenhardt A; Beaufils P; Coumel P; Slama R
    Arch Mal Coeur Vaiss; 1994 Jan; 87(1):57-63. PubMed ID: 7811152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of systematic programmed ventricular stimulation after myocardial infarction. Which protocol should be recommended?].
    Brembilla-Perrot B; de La Chaise AT; Beurrier D; Martin N; Thiel B; Suty-Selton C; Louis P
    Arch Mal Coeur Vaiss; 1993 Oct; 86(10):1453-7. PubMed ID: 8010843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Arrhythmia risk stratification in patients with heart failure: prognostic evaluation of arrhythmia risk].
    Lombardi F
    Ital Heart J Suppl; 2001 Dec; 2(12):1284-90. PubMed ID: 11838349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial.
    Sweeney MO; Wathen MS; Volosin K; Abdalla I; DeGroot PJ; Otterness MF; Stark AJ
    Circulation; 2005 Jun; 111(22):2898-905. PubMed ID: 15927965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk factors and prevention of sudden cardiac death in patients with ventricular tachycardia after myocardial infarct].
    Kaliská G; Szentiványi M; Kmec P; Alberty R
    Vnitr Lek; 1999 Jan; 45(1):22-9. PubMed ID: 10422522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of left ventricular ejection fraction and inducible ventricular tachycardia in ST-elevation myocardial infarction treated by primary angioplasty versus thrombolysis.
    Chong JJ; Ganesan AN; Eipper V; Kovoor P
    Am J Cardiol; 2008 Jan; 101(2):153-7. PubMed ID: 18178398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes of inducible very fast ventricular tachycardia (cycle length 200-250 ms) in patients with ischemic cardiomyopathy.
    Kumar S; Sivagangabalan G; Choi MC; Eipper V; Thiagalingam A; Kovoor P
    J Cardiovasc Electrophysiol; 2010 Mar; 21(3):262-9. PubMed ID: 19817927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of ventricular tachycardia induction in syncopal patients with mild to moderate left ventricular dysfunction.
    Fazelifar AF; Ashrafi P; Haghjoo M; Haghighi ZO; Abkenar HB; Ashour A; Azari S; Forghanian A; Sadr-Ameli MA
    Cardiol J; 2009; 16(4):327-31. PubMed ID: 19653175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing of life-threatening arrhythmias detected by implantable cardioverter-defibrillators in relation to changes in cosmophysical factors.
    Stoupel E; Kusniec J; Mazur A; Abramson E; Israelevich P; Strasberg B
    Cardiol J; 2008; 15(5):437-40. PubMed ID: 18810718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy.
    Metcalf RG; Sanders P; James MJ; Cleland LG; Young GD
    Am J Cardiol; 2008 Mar; 101(6):758-61. PubMed ID: 18328835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Haigney MC; Zareba W; Gentlesk PJ; Goldstein RE; Illovsky M; McNitt S; Andrews ML; Moss AJ;
    J Am Coll Cardiol; 2004 Oct; 44(7):1481-7. PubMed ID: 15464332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.